Effects of rosiglitazone on the atherosclerosis and oxidative stress in diabetic rabbits / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 17-18, 2010.
Article
in Zh
| WPRIM
| ID: wpr-391556
Responsible library:
WPRO
ABSTRACT
Rosiglitazone was used for intervention of atherosclerosis in diabetic rabbits.The results showed that the intima/medium thickness ratio,cross section area of plaque,and the expressions of NADPH oxidase p22phox,gp91 phox were decreased;while the total anti-oxidative ability was increased after administration of rosiglitazone as compared with the non-intervention group(all P<0.05).Compared with rosiglitazone treatment group,serum hepatocuprein leveI in rosiglitazone prevention group was increased,while serum malonaldehyde level decreased(both P<0.05).This study suggests that rosiglitazone may have the effect of reducing the oxidative stress and the formation of atherosclerotic plaque in diabetics.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Endocrinology and Metabolism
Year:
2010
Type:
Article